Sonja Anlauf
17Patents
5h-index
53Co-inventors
65Inventor score
Filing activity: May 6, 2004 → Apr 4, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8889700B2 | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | Chemistry; Metallurgy | 17 | Active |
| US9957235B2 | Benzimidazol-2-amines as mIDH1 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US9951027B2 | Benzimidazol-2-amines as MIDH1 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US8691817B2 | Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof | Chemistry; Metallurgy | 5 | Active |
| US8288402B2 | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | Chemistry; Metallurgy | 5 | Active |
| US7368424B2 | Acylated nonadepsipeptides | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7531507B2 | Acylated nonadepsipeptides containing pyridyl alanine residues | Human Necessities | 4 | Expired |
| US10137110B2 | 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors | Chemistry; Metallurgy | 4 | Active |
| US8569314B2 | Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD | Chemistry; Metallurgy | 3 | Active |
| US9174997B2 | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof | Chemistry; Metallurgy | 3 | Active |
| US8076285B2 | Lysobactin amides | Human Necessities | 0 | Active |
| US9359362B2 | Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD | Chemistry; Metallurgy | 0 | Active |
| US11136296B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | Human Necessities | 0 | Active |
| US7786079B2 | Substituted nonadepsipeptides | Human Necessities | 0 | Active |
| US7718611B2 | Cyclic nonapeptide amides | Human Necessities | 0 | Active |
| US10442772B2 | Benzimidazol-2-amines as mIDH1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7727956B2 | Deoxonadepsipeptides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.